Hideyuki Akaza, M.D.

Department of Strategic investigation on comprehensive cancer network Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies.
The University of Tokyo, Japan

1980

M.D. The University of Tokyo, Japan

1982

Visiting assistant professor, University of Tennessee, USA

1986

Lecturer, Department of Urology, Faculty of Medicine, the University of Tokyo

1990-1996

Associate professor, Department of Urology, Institute of Clinical Medicine, University of Tsukuba

1997-2004

Professor and Chairman, Department of Urology, Institute of Clinical Medicine, University of Tsukuba 2000-2009 Deputy Director of Tsukuba University Hospital

2004-2010

Professor & Chairman, Urology & Andrology, Doctoral Program in Clinical Sciences, Post-graduate, University of Tsukuba

2008-2010

Director, Tsukuba General Cancer Clinic Center

2010-

Emeritus Professor, University of Tsukuba

2010-2015

Professor, Research Center for Advanced Science and Technology, the University of Tokyo

2014-

Member, Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies, The University of Tokyo

2015-

Professor, Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies, The University of Tokyo

• The Japanese Urological Association Sakaguchi Prize (1982)
• Executive member of Japan Society of Clinical Oncology (1999-2006)
• Expert committee member of Ministry of Health, Labour and Welfare
• Executive member of The Japanese Urological Association
• Executive member of Japanese Biotherapy Association
• Committee member of Japanese Cancer Association
• President of The 44th Annual Meeting of Japan Society of Clinical Oncology (2006)
• The Japan Society of Clinical Oncology Komei Nakayama Prize (2007)
• Chairperson of 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment
• President of the 20th Asia Pacific Cancer Conference
• President of Asia Pacific Society of Urological Oncology
• Director of UICC-ARO (Asian regional office)
• Member of UICC TNM Expert Panel Genitourinary Cancer
• Vice Secretary General of the Asian and Pacific Federation of Organization for Cancer Research and Control (APFOCC)
• Chair of NCCN Asian Consensus Statement
• Distinguished Service Award for Japanese Urology (2014)

1. Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy. J Clin Oncol 2009;27: 4306-4313
2. Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level. Jpn J Clin Oncol. 2011; 41: 1023-30.
3. Prostate Cancer Chemoprevention by Soy isoflavones-Role of intestinal bacteria as the "second human genome". Cancer Sci 2012; 103: 969-75.
4. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci 2013; 104(1):22-7.
5. Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non-communicable diseases political declaration in Asia. Cancer Sci 2013; 104(6):773-8
6. Cross-boundary Cancer Studies at the University of Tokyo: Surviving Cancer in Asia, Ed. Akaza H, Kawahara N, Jpn J Clin Oncol,2014; 44(Supple 1)